SAN DIEGO, Dec. 19, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its Vice President of Operations, Blake N. Schroeder, Esq., has been promoted to Chief Operating Officer. Schroeder will also remain in his dual role as Chief Executive Officer of Medical Marijuana, Inc. subsidiary Kannaway®, which sells hemp-based botanical products for health and wellness.
Schroeder, who joined Medical Marijuana, Inc. and Kannaway® in March of 2016, has more than 10 years of experience leading international direct sales companies, with extensive experience in the nutrition industry ranging from legal and regulatory insight to overseeing all aspects of global sales, product development, marketing, distribution and operations.
"We are proud to have Blake as a senior leader and this promotion is well-deserved," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "Since joining our organization, Blake has delivered dramatic performance results, pioneered new business strategies and helped improve our operations and brand presence worldwide. We're confident in his ability to take us to yet another level of success. Blake is known for his ability to drive significant revenue increases and Medical Marijuana, Inc. was pleased to announce that throughout Q3 2017, we shattered monthly and daily sales records, with a year-over-year increase of 255%."
"I'm excited about my expanded role at Medical Marijuana, Inc. and look forward to helping drive the organization's continued growth, contribute to its strategic direction, and provide access to CBD to more people than ever across the globe," said Schroeder.
In Nov. 2017, Kannaway® – the Medical Marijuana, Inc. subsidiary for which Schroeder serves as CEO – announced its largest-ever revenue month in the history of the Company and the launch of several new products.
Schroeder holds a B.S. in Finance from Utah State University, as well as a J.D. from Syracuse University College of Law.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
SOURCE Medical Marijuana, Inc.